Biotech
ICoNS 2026
ICoNS welcomes thought-leaders across all fields that are actively participating in newborn sequencing implementation projects, or are imminently preparing to do so. Oxford Nanopore are sponsoring and exhibiting at this event.
3Speakers
2Sponsors
2Exhibitors
3Sessions
5Companies · in total
Speakers
Programmed at ICoNS, in alphabetical order.
Eric Joo
University of Melbourne
Neblina Sikta
Clinical Bioinformatician · Victorian Clinical Genetics Services (VCGS)
Zoe Ward
University of Auckland
Sponsors
The companies behind the program. Tiers as disclosed.
Agenda
Selected from 3 sessions.
- Monday, 3 August 2026 | 14:45 - 15:05Oxford Nanopore Industry Session
Using Oxford Nanopore Technologies long-read sequencing to resolve unexplained hereditary colorectal cancer and polyposis syndrome patients
Background: Current hereditary colorectal cancer multigene panel testing uses conventional short-read next-generation sequencing, which can miss complex genetic variations such as …
- Monday, 3 August 2026 | 15:05 - 15:25Oxford Nanopore Industry Session
Genetic testing solves mystery of teens’ sudden deaths
- Monday, 3 August 2026 | 15:25 - 15:45Oxford Nanopore Industry Session
Genome-wide phasing using routine clinical samples
Accurate haplotype phasing is critical for clinical variant interpretation, particularly for resolving cis/trans relationships in recessive Mendelian disease. Long-read sequencing …
Company intelligence
What does it mean when 5 companies show up, and 2 bet on three roles at once?
Five companies. two are betting more than once.
The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.